<DOC>
	<DOCNO>NCT02899741</DOCNO>
	<brief_summary>The purpose study determine whether omega-3 effective treatment medically intractable epilepsy adjunctive therapy .</brief_summary>
	<brief_title>Efficacy Omega-3 Adjunctive Therapy Medically Intractable Epilepsy : A Prospective Open-label Pilot Study</brief_title>
	<detailed_description>This study enroll total 30 patient medically intractable epilepsy . The patient fully assessed enrollment , seizure frequency count three month without change medication . After three month , Omega-3 administer next three month . Seizure frequency , questionnaires evaluate mood QOL , adverse event evaluate visit .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<criteria>Patients medically intractable , focal generalize , epilepsy : Patients localizationrelated partial onset generalize tonic/clonic seizure accord International League Against Epilepsy ( ILAE ) include . Medically intractable epilepsy mean recurrent seizure occur even though two antiepileptic drug use appropriately one year . Seizure frequency criterion : three seizure per one month recent 3 month enrollment Seizure criterion : simple partial , complex partial , tonicclonic seizure Subjects normal cognitive function : patient perform normal daily life . If definite , enrollment do KMMSE score 27 . Poor general medical condition : comorbid heart , lung , liver disease Patients history pseudoseizure Antiepileptic drug change recent one month . Chronic alcoholic Seizure count do since seizure occur successively . Allergy fish High risk bleed trauma operation Liver function abnormality Pregnant lactate woman , woman plan child Patients participate clinical trial recent one month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Medically intractable epilepsy , Omega-3</keyword>
</DOC>